Last reviewed · How we verify
NCT05646615
Experiences and Health-related Quality of Life of Informal Caregivers of Dialysis Patients
trial in Peritoneal Dialysis in 202 participants. Completed in 31 December 2023.
31 December 2023
Quick facts
| Lead sponsor | B.C. van Jaarsveld |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 202 |
| Start date | 1 January 2018 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 33 locations across Belgium, Netherlands |
Conditions studied
- Peritoneal Dialysis — all drugs for Peritoneal Dialysis →
- Hemodialysis, Home — all drugs for Hemodialysis, Home →
- Hemodialysis — all drugs for Hemodialysis →
- Quality of Life — all drugs for Quality of Life →
Sponsor
B.C. van Jaarsveld
Who can join
18 and older, any sex, with Peritoneal Dialysis or Hemodialysis, Home. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this prospective, observational, multicentre cohort study is to assess the trajectory of the experiences (both positive and negative) and health-related quality of life (HRQOL) of informal caregivers of patients who start home dialysis, and compare these to experiences and HRQOL of informal caregivers of patients who start in-centre hemodialysis. The investigators hypothesise that informal caregivers of home dialysis patients experience more positive experiences, but also more negative experiences, and still have better HRQoL, compared with caregivers of in-centre HD patients. Participants will fill in five different validated questionnaires and questions on required support. Participants are asked to fill in the questionnaires after inclusion (i.e., start of dialysis), and at 6 and 12 months after start dialysis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Informal caregiver burden in dialysis care and how it relates to patients' health-related quality of life and symptoms.
Driehuis E, Janse RJ, Roeterdink AJ, Konijn WS, et al · · 2024 · cited 10× · PMID 39493262 · DOI 10.1093/ckj/sfae300
Verify or expand the search:
- PubMed search for NCT05646615
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peritoneal Dialysis
Currently open trials in the same condition.
- NCT07098351 — Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis · NA · recruiting
- NCT07077538 — Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients · NA · recruiting
- NCT06876987 — The Mobile-based Training System in Peritoneal Dialysis Patients · NA · recruiting
- NCT06641765 — Continuous Glucose Monitoring in Dialysis Patients With Diabetes · NA · active not recruiting
- NCT06368713 — Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05646615 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by B.C. van Jaarsveld
- Last refreshed: 12 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05646615.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing